Company News

bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this collaboration is helping accelerate the development of individualized cancer treatments.

bioMérieux is partnering with AdventHealth Orlando as they become the first institution to adopt the VITEK® REVEAL™ Fast Antimicrobial Susceptibility Testing (AST) System for clinical use in the United States.

BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare.

bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.

bioMérieux, Tampa General Hospital (TGH) and USF Health hosted the inaugural U.S. AMR Summit Nov. 12-13 to address the escalating global threat of antimicrobial resistance (AMR).